Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet (Glucim-P1)

Glimepiride 1 + Metformin 500 + Pioglitazone 15 mg — Triple OAD

Glucim-P1 SR Tablet — Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg
Dosage Form Tablet
Pack Type Box
Pack Size 20 x 15 (Blister)
MRP ₹ 2200
Therapy Cardiac + Diabetic — Sulphonylurea + biguanide + thiazolidinedione (Triple OAD)
Storage Store below 25°C.

WhatsApp EnquiryCall: +919041677932

For chemists, distributors and doctors: Glucim-P1 (glimepiride 1 mg + metformin 500 mg + pioglitazone 15 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.

WhatsApp for price list & availability

Buying this composition for PCD franchise, wholesale or under your own brand? See Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet – manufacturer, supplier & PCD franchise for available packs and brand options.

See the full antidiabetic tablets range – manufacturer, supplier and PCD franchise: SGLT2 and DPP-4 inhibitors, glimepiride, gliclazide, metformin, voglibose and their combinations.

Schedule G: Metformin is listed in Schedule G of the Drugs Rules, 1945, so the pack carries the red-box caution “SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision”. Combinations that also contain a Schedule H molecule carry the Rx label too. See the Schedule G drugs list.

About Glucim-P1 SR Tablet

Glucim-P1 SR Tablet combines three complementary oral antidiabetic agents: Glimepiride 1 mg (sulphonylurea — stimulates insulin secretion), Metformin 500 mg (biguanide — reduces hepatic glucose output) and Pioglitazone 15 mg (thiazolidinedione — improves peripheral insulin sensitivity).

The triple combination is indicated for type-2 diabetes patients with significant insulin resistance who fail dual oral therapy and need glycaemic intensification before insulin.

Camrut Healthcare manufactures Glucim-P1 under WHO-GMP conditions for PCD pharma franchise across India.

Glucim-P1 का उपयोग (हिंदी में): टाइप 2 डायबिटीज़ (शुगर) की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।

Indications

  • Type-2 DM uncontrolled on dual OAD
  • Significant insulin resistance
  • Glycaemic step-up prior to insulin initiation

Mechanism of Action

Glimepiride closes pancreatic beta-cell ATP-sensitive K+ channels, triggering insulin secretion. Metformin activates AMPK, suppressing hepatic gluconeogenesis and improving peripheral glucose utilisation. Pioglitazone is a PPAR-gamma agonist that increases insulin-sensitive gene expression in adipose and muscle tissue.

Dosage & Administration

  • Adults: 1 tablet once daily before breakfast
  • Swallow whole
  • Monitor liver enzymes and fluid status
  • Use under physician supervision

Side Effects

  • Hypoglycaemia (sulphonylurea)
  • GI upset (metformin)
  • Weight gain and fluid retention (pioglitazone)
  • Anaemia
  • Macular oedema (rare)

Contraindications & Precautions

  • Type-1 diabetes
  • NYHA Class III–IV heart failure
  • Active bladder cancer
  • Severe renal or hepatic impairment
  • Pregnancy and breastfeeding

Storage

Store below 25°C.

From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the cardiac-diabetic products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare cardiac diabetic PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.

PCD Pharma Franchise & Third-Party Manufacturing
Glucim-P1 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.